Transcatheter valve implantation benefits even very elderly

Transcatheter valve implantation benefits even very elderly

(HealthDay)—Transcatheter aortic valve implantation is associated with acceptable clinical outcomes, even among very elderly patients, according to a study published in the January issue of the Annals of Thoracic Surgery.

Masanori Yamamoto, M.D., from the Centre Hospitalier Universitaire Henri Mondor in Créteil, France, and colleagues examined age-specific differences in clinical outcomes for 867 patients aged 80 to 84 years; 1,064 patients aged 85 to 89 years; and 349 patients aged ≥90 years. All patients were enrolled in the French national transcatheter aortic valve implantation registry.

The researchers observed no differences among groups in the rates of procedural success, complications, or length of hospitalization. There were no significant differences between the groups in cumulative 30-day (10.3, 9.5, and 11.2 percent, respectively, for those aged 80 to 84 years, 85 to 89 years, and ≥90 years; P = 0.53). No significant differences were seen in cumulative one-year mortalities, although the mortality rate was higher in patients aged 85 to 89 and ≥90 years compared with those aged 80 to 84 years (19.8 versus 26.1 and 27.7 percent, respectively; P = 0.16). Patient age (85 to 89 and ≥90 versus 80 to 84 years) was not associated with increased 30-day mortality risk (hazard ratios, 0.92 [P = 0.38] and 1.26 [P = 0.28], respectively) or with one-year mortality risk (hazard ratios, 1.16 [P = 0.25] and 1.36 [P = 0.073], respectively), after adjustment for baseline characteristics and potential confounders.

"Transcatheter implantation may be a good therapeutic option even in very elderly patients (85 to 89 years and ≥90 years)," the authors write.

Several authors disclosed financial ties to the medical device industry.

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

TAVI feasible in bicuspid aortic valve

Sep 02, 2013

Transcatheter aortic valve implantation (TAVI) is feasible in patients with bicuspid aortic valve, according to research presented at ESC Congress 2013 today by Dr. Timm Bauer from Germany. The findings open ...

TAVI is safe alternative to redo cardiac surgery

Sep 02, 2013

TAVI is a safe alternative to redo cardiac surgery for failing bioprosthetic valves, according to research presented at the ESC Congress today by Dr. Spyridon Katsanos from the Netherlands. The findings suggest that transcatheter ...

Results of the REPRISE II trial reported

Nov 01, 2013

In a clinical trial, a second-generation transcatheter aortic valve demonstrated low rates of complications that are sometimes seen in transcatheter aortic valve replacement (TAVR), including challenges with positioning, ...

Recommended for you

Viagra protects the heart beyond the bedroom

3 hours ago

Viagra could be used as a safe treatment for heart disease, finds new research published today in the open access journal BMC Medicine. The study reveals that long-term daily treatment of Viagra can provide protection for th ...

Years of endurance exercise may raise A-fib/Flutter risk

Oct 18, 2014

(HealthDay)—Cumulative years of regular endurance exercise are associated with an increased risk for atrial fibrillation and atrial flutter, according to a study published in the Oct. 15 issue of The Am ...

User comments